What is risk stratum of pediatric ALL using patient case? - Answers
What labs are suggestive of ALL? - Answers WBC: 70.3 (5-15 is normal)
Hgb: 5.8 (10.5-13.5)
Plt: 36 (150 - 400)
Blasts: 89.0
What is the etiology? - Answers most common pediatric malignancy (leading cause of childhood cancer
death)
overall survival rates currently ~90%
peak incidence 2-5 years old
boys > girls, white hispanic > Black, Asian
higher incidence in industrial countries
Diagnosis of ALL? - Answers symptoms are are non-specific
procedures (bone marrow biopsy and lumbar puncture)
Pathophysiology of ALL? - Answers T lymphocyte (10%)
B lymphocyte (90%)
What is CNS Status? - Answers CNS 1: no leukemia cells present on CSF studies
, CNS 2: less than 5 WBCs + Blasts on CSF studies
CNS 3: greater than equal to 5 WBCs + Blasts on CSF studies
What is important to know about intrathecal chemo? - Answers direct injection into CNS
used for both treatment of CNS disease and prophylaxis against development of CNS disease (systemic
chemo has limited CNS penetration)
limited systemic penetration
*most common - intrathecal cytarabine*
- may also give methotrexate or "triple IT" (cytarabine + methotrexate + hydrocortisone)
What is the treatment of TLS? - Answers start hydration at 1.5 to 2x maintenance rate
give *single dose of raburicase 0.2mg/kg; cap dose at 6mg* --expensive / will not get rid of new uric acid
production
*start allopurinol 10/mg/kg/day divided TID* --inhibit xanthine oxidase and prevent uric acid crystals
*start sevelamer 800mg TID with meals* -- prevent calcium / phosphorus precipitate formation -- does
not do anything for the phos that is there (this is a phos binder)
What is TLS? - Answers tumor lysis syndrome (fairly common in ALL)
tumor cells lyse (either spontaneously or as a result of chemotherapy) -- will release all of the
intracellular components (DNA)